Национальный Медицинский Университет Имени А.А. Богомольца
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Национальный Медицинский Университет Имени А.А. БогомольцаfiledCriticalНациональный Медицинский Университет Имени А.А. Богомольца
Priority to UAU201304882UpriorityCriticalpatent/UA83275U/en
Publication of UA83275UpublicationCriticalpatent/UA83275U/en
Investigating Or Analysing Biological Materials
(AREA)
Abstract
A method for predicting the treatment outcome of the psoriatic lesions of skin in the patients with psoriatic arthritis provides for the assaying C-reactive protein. Prior to Leflunamide treatment, PASI index is assessed. The positive treatment outcome is predicted when PASI ≥ 7.7.
UAU201304882U2013-04-172013-04-17Method for predicting treatment outcome of psoriatic lesions of skin in patients with psoriatic arthritis
UA83275U
(en)